PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Mus

Go back to PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Mus
(NASDAQ: ELAB) Delayed: 4.85 -0.36 (6.91%)
Previous Close $5.21    52 Week High
Open $5.21    52 Week Low
Day High $5.35    P/E N/A 
Day Low $4.82    EPS
Volume 30,180       

(NASDAQ: ELAB) Delayed: 4.85 -0.36 (6.91%)
Previous Close $5.21    52 Week High
Open $5.21    52 Week Low
Day High $5.35    P/E N/A 
Day Low $4.82    EPS
Volume 30,180